Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily. - Eder,J.P.; Supko,J.G.; Clark,J.W.; Puchalski,T.A.; Garcia-Carbonero,R.; Ryan,D.P.; Shulman,L.N.; Proper,J.; Kirvan,M.; Rattner,B.; Connors,S.; Keogan,M.T.; et al. (J Clin Oncol, 2002)